Senseonics Holdings, Inc. Common Stock (SENS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Senseonics Holdings, Inc. Common Stock stock (SENS) is currently trading at $6.66. Senseonics Holdings, Inc. Common Stock PS ratio (Price-to-Sales) is 7.68. Analyst consensus price target for SENS is $18.92. WallStSmart rates SENS as Sell.
- SENS PE ratio analysis and historical PE chart
- SENS PS ratio (Price-to-Sales) history and trend
- SENS intrinsic value — DCF, Graham Number, EPV models
- SENS stock price prediction 2025 2026 2027 2028 2029 2030
- SENS fair value vs current price
- SENS insider transactions and insider buying
- Is SENS undervalued or overvalued?
- Senseonics Holdings, Inc. Common Stock financial analysis — revenue, earnings, cash flow
- SENS Piotroski F-Score and Altman Z-Score
- SENS analyst price target and Smart Rating
Senseonics Holdings, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Senseonics Holdings, Inc. Common Stock (SENS) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in revenue growth. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Senseonics Holdings, Inc. Common Stock (SENS) Key Strengths (1)
Revenue surging 71.80% year-over-year
Supporting Valuation Data
Senseonics Holdings, Inc. Common Stock (SENS) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Premium valuation at 7.7x annual revenue
Premium pricing at 4.4x book value
Low institutional interest, mostly retail-driven
Supporting Valuation Data
Senseonics Holdings, Inc. Common Stock (SENS) Detailed Analysis Report
Overall Assessment
This company scores 25/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 1 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 2.1/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Revenue Growth. Growth metrics are encouraging with Revenue Growth at 71.80%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Sales (7.68), Price/Book (4.42) suggest expensive pricing. Profitability pressure is visible in Return on Equity at -168.30%, Operating Margin at -146.80%, Profit Margin at -196.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -168.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 71.80% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SENS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SENS's Price-to-Sales ratio of 7.68x trades at a deep discount to its historical average of 315.49x (57th percentile). The current valuation is 100% below its historical high of 4279.39x set in Aug 2016, and 1247% above its historical low of 0.57x in Nov 2024. Over the past 12 months, the PS ratio has expanded from ~1.2x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Senseonics Holdings, Inc. Common Stock (SENS) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Senseonics Holdings, Inc. Common Stock is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 35M with 72% growth year-over-year. The company is currently unprofitable, posting a -196.0% profit margin.
Key Findings
Revenue growing at 72% YoY, reaching 35M. This pace significantly outperforms most MEDICAL DEVICES peers.
Spending 20% of revenue (7M) on R&D, reinforcing its commitment to innovation and future growth.
The company is unprofitable with a -196.0% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -18M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Senseonics Holdings, Inc. Common Stock maintain 72%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Senseonics Holdings, Inc. Common Stock.
Bottom Line
Senseonics Holdings, Inc. Common Stock is a high-conviction growth story with revenue accelerating at 72% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin -196.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Senseonics Holdings, Inc. Common Stock(SENS)
NYSE MKT
HEALTHCARE
MEDICAL DEVICES
USA
Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company is headquartered in Germantown, Maryland.